Arch Therapeutics Inc (ARTH)

[D theG]

No problem with that, but you heard nothing positive in the call last night? he explained exactly what they were going to do and when they would do it, and that was the most expeditious route. Like I mentioned before, the sensitization issue was the only thing brought up, the rest of the application was sufficient, that is a big win. There are many companies even the big well funded ones that need to go through many application attempts before having an approval.